Omics data discovery agents: Agent-supported retrieval, reanalysis, and synthesis of published omics data.

IF 3.6 2区 生物学 Q1 BIOCHEMICAL RESEARCH METHODS
PLoS Computational Biology Pub Date : 2026-10-06 eCollection Date: 2026-10-01 DOI:10.1371/journal.pcbi.1014822
Alexandre Hutton, Jesse G Meyer
{"title":"Omics data discovery agents: Agent-supported retrieval, reanalysis, and synthesis of published omics data.","authors":"Alexandre Hutton, Jesse G Meyer","doi":"10.1371/journal.pcbi.1014822","DOIUrl":null,"url":null,"abstract":"<p><p>The biomedical literature contains a vast collection of omics studies, yet most published data remain functionally inaccessible for computational reuse. When raw data are deposited in public repositories, essential information for reproducing reported results is dispersed across main text, supplementary files, and code repositories, and in the rarer cases where intermediate data (e.g., protein abundance files) are shared, their location is irregular. Here we present an agentic framework for the agent-supported retrieval, reanalysis, and synthesis of published omics data. The system employs large language model (LLM) agents with access to tools for fetching omics studies, extracting article metadata, identifying and downloading published data, executing containerized quantification pipelines, and synthesizing results across studies. Applied at corpus scale, the pipeline catalogued dataset references across thousands of PubMed Central articles; we report these as descriptive system outputs rather than as a validated measure of extraction accuracy. Using model context protocol (MCP) servers to expose containerized analysis tools, the agents retrieved and re-quantified data in five end-to-end reanalyses spanning data-dependent and data-independent proteomics and bulk RNA-seq. All five reanalyses completed, each with documented human guidance and workflow accommodations, and reproduced the authors' deposited abundances with high per-sample correlation (0.85-0.997) and strongly concordant differentially expressed features (fold-change Spearman 0.88-0.91), with no direction reversals among features called differentially expressed in both analyses; residual differences in significant-feature lists were attributable to threshold placement, tool-version, and preprocessing differences rather than to the underlying quantities. We further demonstrate that agents can identify semantically similar studies, judge data compatibility, and synthesize findings across studies, including a random-effects meta-analysis that recovered consistent protein regulation in liver fibrosis. Rather than a validated benchmark of literature-wide performance, this work is a feasibility demonstration together with an auditable, reusable toolset, establishing a foundation for prospective evaluation of automated omics-data reuse.</p>","PeriodicalId":20241,"journal":{"name":"PLoS Computational Biology","volume":"22 10","pages":"e1014822"},"PeriodicalIF":3.6000,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13652336/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PLoS Computational Biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1371/journal.pcbi.1014822","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

The biomedical literature contains a vast collection of omics studies, yet most published data remain functionally inaccessible for computational reuse. When raw data are deposited in public repositories, essential information for reproducing reported results is dispersed across main text, supplementary files, and code repositories, and in the rarer cases where intermediate data (e.g., protein abundance files) are shared, their location is irregular. Here we present an agentic framework for the agent-supported retrieval, reanalysis, and synthesis of published omics data. The system employs large language model (LLM) agents with access to tools for fetching omics studies, extracting article metadata, identifying and downloading published data, executing containerized quantification pipelines, and synthesizing results across studies. Applied at corpus scale, the pipeline catalogued dataset references across thousands of PubMed Central articles; we report these as descriptive system outputs rather than as a validated measure of extraction accuracy. Using model context protocol (MCP) servers to expose containerized analysis tools, the agents retrieved and re-quantified data in five end-to-end reanalyses spanning data-dependent and data-independent proteomics and bulk RNA-seq. All five reanalyses completed, each with documented human guidance and workflow accommodations, and reproduced the authors' deposited abundances with high per-sample correlation (0.85-0.997) and strongly concordant differentially expressed features (fold-change Spearman 0.88-0.91), with no direction reversals among features called differentially expressed in both analyses; residual differences in significant-feature lists were attributable to threshold placement, tool-version, and preprocessing differences rather than to the underlying quantities. We further demonstrate that agents can identify semantically similar studies, judge data compatibility, and synthesize findings across studies, including a random-effects meta-analysis that recovered consistent protein regulation in liver fibrosis. Rather than a validated benchmark of literature-wide performance, this work is a feasibility demonstration together with an auditable, reusable toolset, establishing a foundation for prospective evaluation of automated omics-data reuse.

组学数据发现代理:代理支持的已发布组学数据的检索、再分析和合成。
生物医学文献包含了大量的组学研究,但大多数已发表的数据仍然无法在功能上进行计算重用。当原始数据存储在公共存储库中时,用于再现报告结果的基本信息分散在主文本、补充文件和代码存储库中,并且在共享中间数据(例如,蛋白质丰度文件)的极少数情况下,它们的位置是不规则的。在这里,我们提出了一个代理框架,用于代理支持检索,再分析和合成已发表的组学数据。该系统采用大型语言模型(LLM)代理,可以访问获取组学研究、提取文章元数据、识别和下载已发布数据、执行容器化量化管道以及综合研究结果的工具。应用于语料库规模,管道编目了数千篇PubMed Central文章中的数据集参考;我们将这些报告为描述性系统输出,而不是作为提取准确性的验证度量。使用模型上下文协议(MCP)服务器公开容器化分析工具,代理在跨越数据依赖和数据独立的蛋白质组学和大量RNA-seq的五个端到端再分析中检索和重新量化数据。所有五次重新分析都完成了,每一次都有记录的人类指导和工作流程调整,并再现了作者的沉积丰度,具有高的每样本相关性(0.85-0.997)和强烈一致的差异表达特征(折叠变化Spearman 0.88-0.91),在两种分析中称为差异表达的特征之间没有方向逆转;显著特征列表中的剩余差异可归因于阈值位置、工具版本和预处理差异,而不是底层数量。我们进一步证明,药物可以识别语义相似的研究,判断数据兼容性,并综合研究结果,包括随机效应荟萃分析,恢复肝纤维化中一致的蛋白质调节。这项工作不是对文献范围内的性能进行验证的基准测试,而是与可审计的、可重用的工具集一起进行可行性演示,为自动化组学数据重用的前瞻性评估奠定了基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
PLoS Computational Biology
PLoS Computational Biology BIOCHEMICAL RESEARCH METHODS-MATHEMATICAL & COMPUTATIONAL BIOLOGY
CiteScore
7.10
自引率
4.70%
发文量
820
审稿时长
2.5 months
期刊介绍: PLOS Computational Biology features works of exceptional significance that further our understanding of living systems at all scales—from molecules and cells, to patient populations and ecosystems—through the application of computational methods. Readers include life and computational scientists, who can take the important findings presented here to the next level of discovery. Research articles must be declared as belonging to a relevant section. More information about the sections can be found in the submission guidelines. Research articles should model aspects of biological systems, demonstrate both methodological and scientific novelty, and provide profound new biological insights. Generally, reliability and significance of biological discovery through computation should be validated and enriched by experimental studies. Inclusion of experimental validation is not required for publication, but should be referenced where possible. Inclusion of experimental validation of a modest biological discovery through computation does not render a manuscript suitable for PLOS Computational Biology. Research articles specifically designated as Methods papers should describe outstanding methods of exceptional importance that have been shown, or have the promise to provide new biological insights. The method must already be widely adopted, or have the promise of wide adoption by a broad community of users. Enhancements to existing published methods will only be considered if those enhancements bring exceptional new capabilities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书